DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
- Conditions
- Meningeal Neoplasms
- Registration Number
- NCT00029523
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Brief Summary
The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Progression-free survival, defined as the time to neurological progression or death
- Secondary Outcome Measures
Name Time Method Time to neurological progression; Survival (all-cause and meningeal disease-specific) Frequency of improvement in pre-existing meningeal-disease related neurological deficits Karnofsky Performance Scores (KPS) Quality of life Cytological response rate Overall safety profile
Trial Locations
- Locations (23)
Barrow Neurological Institute
🇺🇸Phoenix, Arizona, United States
Alta Bates Comprehensive Cancer Center
🇺🇸Berkeley, California, United States
University of Southern California, Norris Cancer Center
🇺🇸Los Angeles, California, United States
University of Colorado Hospital, Anschutz Cancer Pavilion
🇺🇸Denver, Colorado, United States
Georgetown University Medical Center Hematology/Oncology
🇺🇸Washington, District of Columbia, United States
Mayo Clinic, Jacksonville
🇺🇸Jacksonville, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute
🇺🇸Tampa, Florida, United States
Emory Clinic, Department of Neurosurgery
🇺🇸Atlanta, Georgia, United States
Straub Clinic and Hospital
🇺🇸Honolulu, Hawaii, United States
Rush Cancer Institute
🇺🇸Chicago, Illinois, United States
Scroll for more (13 remaining)Barrow Neurological Institute🇺🇸Phoenix, Arizona, United States